Jackob Moskovitz

Jackob Moskovitz

Apr 08, 2019

Group 6 Copy 134
0
    Please wait...

    About This Project

    Oxidized forms of the peptide beta-amyloid (Aβ) are considered to be toxic to the brain, leading to the development of Alzheimer's disease (AD). Based on our preliminary data, we hypothesize that an immunization of an AD-model mice with a recombinant protein enriched with the oxidized amino acid methionine sulfoxide will cause the removal of toxic Aβ from brain. Consequently, this treatment is expected to inhibit the development of AD and alleviate cognitive impairment.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Thermal and Fluid Dynamical Effects on the Efficiency of Hyperpolarized Xenon Production

    The American Lung Association estimates that 32 million Americans are affected by lung diseases, many of which...

    Can we noninvasively measure blood sugar for diabetes?

    Better management of type 1 diabetes is moving towards anartificial pancreas. However, we need a better way...

    You have mail: Stem Cell messages for fighting liver diseases

    The use of stem cells is currently limited by issues including the risk of tumor formation or undesired immune...

    Campaign Ended

    A medicine project funded by 45 people